At CLS Holdings, we have developed a "seed to sale" acquisition strategy that involves acquiring cannabis dispensaries, cultivators and producers. We started with the booming Nevada market, one of the fastest growing markets in the U.S., and have definitive agreements to enter two Massachusetts assets by the end of 2019, as well as a robust pipeline in other Western states.
CLS stands for "Cannabis Life Sciences," in recognition of our patent-pending proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. CLS Holdings has recently received a Notice of Allowance from the U.S. Patent Office for its proprietary extraction and conversion methodology.
CLS is currently operating through Oasis Cannabis, a Las Vegas based vertically integrated cannabis company, which has been completely redesigned and transformed into one of Nevada's top dispensaries. CLS has curated a strong position in the cannabis industry by becoming a revenue producing company and achieving many milestones which have increased shareholder value, including: